Article Details

Pfizer's Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Retrieved on: 2022-11-07 13:10:28

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Paxlovid antiviral drug lowered risk of long COVID symptoms in study. View article details on HISWAI: https://www.stripes.com/theaters/us/2022-11-06/pfizer-paxlovid-antiviral-risk-long-covid-symptoms-7951935.html

Excerpt

Taking Pfizer's Paxlovid antiviral drug within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of ...

Article found on: www.stripes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up